Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines

被引：0

作者：

Focosi, Daniele ^{[1
]}

Franchini, Massimo ^{[2
]}

Senefeld, Jonathon W. ^{[3
]}

Casadevall, Arturo ^{[4
,5
]}

Joyner, Michael J. ^{[3
]}

机构：

[1] Pisa Univ Hosp, North Western Tuscany Blood Bank, Via Paradisa 2, I-56124 Pisa, Italy

[2] Carlo Poma Hosp, Div Transfus Med, I-46100 Mantua, Italy

[3] Mayo Clin, Dept Anesthesiol Perioperat Med, Rochester, MN 55902 USA

[4] Johns Hopkins Sch Publ Hlth, Dept Med, Baltimore, MD 21218 USA

[5] Sch Med, Baltimore, MD 21218 USA

来源：

JOURNAL OF CLINICAL VIROLOGY PLUS | 2023年 / 3卷 / 01期

关键词：

D O I：

10.1016/j.jcvp.2022.100128

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页数：2

共 13 条

[1]

[Anonymous], FDA AUTH REV EV DOS

[2]

[Anonymous], 2022, FDA UPD SOTR EM US A

[3]

Benotmane I, 2022, BREAKTHROUGH COVID 1, V2022

[4] Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9) [J].

Cesaro, Simone ;

Ljungman, Per ;

Mikulska, Malgorzata ;

Hirsch, Hans H. ;

Von Lilienfeld-Toal, Marie ;

Cordonnier, Catherine ;

Meylan, Sylvain ;

Mehra, Varun ;

Styczynski, Jan ;

Marchesi, Francesco ;

Besson, Caroline ;

Baldanti, Fausto ;

Cordoba Masculano, Raul ;

Beutel, Gernot ;

Einsele, Herman ;

Azoulay, Elie ;

Maertens, Johan ;

de la Camara, Rafael ;

Pagano, Livio .

LEUKEMIA, 2022, 36 (06) :1467-1480

[5]

Cruciani M, JAMA NETW OPEN

[6]

Focosi D, 2022, VIRUSES-BASEL, V9, P2560

[7] Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review [J].

Focosi, Daniele ;

Maggi, Fabrizio ;

Franchini, Massimo ;

McConnell, Scott ;

Casadevall, Arturo .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)

[8] Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations [J].

Focosi, Daniele ;

Franchini, Massimo .

EXPERT REVIEW OF VACCINES, 2022, 21 (07) :877-884

[9]

Gupta K, 2022, Rapid relapse of symptomatic SARS-CoV-2 infection following early suppression with nirmatrelvir/ritonavir

[10]

Li M, 2022, BLOOD ADV, V2022

← 1 2 →